Monday, Jul 13th
Last update07:51:49 AM GMT
Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Lilly's research showed some patients on Zyprexa gained as much as 80 pounds and that the incidence of high blood sugar at diabetes levels was 3.5 times higher than for placebos, according to documents filed in a lawsuit brought by the state of Alaska.
 One in four Israelis now engages in harmful substance use as the psychological fallout from Israel’s... |
 New York City’s famed Solomon R Guggenheim Museum was among a number of Manhattan buildings that... | ||
 Martha Lillard, who contracted polio at age five and spent most of her life dependent on... |
 The state of New York this week sued several companies over “forever chemicals,” a family of... |
